Martin Kolb

Martin Kolb is the Jack Gauldie Boehringer Ingelheim Chair in Interstitial Lung Disease and Research Director of the Firestone Institute for Respiratory Health, McMaster University and St. Joseph’s Healthcare, Hamilton, Ontario, Canada. His major research interests are fibrotic lung disease, with a particular interest in the role of growth factors, matrix abnormalities and pulmonary vessel remodeling in disease progression. He works in biomarker development for lung fibrosis and is a Principal Investigator and steering committee member in numerous ILD clinical trials. Professor Kolb has authored over 350 peer-reviewed publications on different basic science and clinical topics with an H-Factor above 80. He was the Chief-Editor of the European Respiratory Journal (2018-2022) and currently is the journal’s Section Editor for Interstitial Lung Disease. He is an editorial board member of several journals, including American Journal of Respiratory and Critical Care Medicine. He also serves as Chair of the Ethics and Integrity Committee of the European Respiratory Society and is Secretary and President-Elect of the Canadian Thoracic Society.